Meeder Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Meeder Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-181	Closed	-$1K	–	2682
2020 Q1	$1K	Buy	+181	New	+$2.26K	﹤0.01%	2286
2019 Q3	–	Sell	-289	Closed	-$8K	–	2334
2019 Q2	$8K	Buy	+289	New	+$9.06K	﹤0.01%	1543
2018 Q1	–	Sell	-85	Closed	-$4K	–	1820
2017 Q4	$4K	Sell	85 -606	-88%	-$30.7K	﹤0.01%	1398
2017 Q3	$38K	Buy	691 +357	+107%	+$21K	﹤0.01%	743
2017 Q2	$19K	Sell	334 -153	-31%	-$6.13K	﹤0.01%	840
2017 Q1	$19K	Sell	487 -409	-46%	-$13K	﹤0.01%	737
2016 Q4	$20K	Buy	+896	New	+$17.5K	﹤0.01%	661
2016 Q3	–	Sell	-3,865	Closed	-$91K	–	1018
2016 Q2	$91K	Buy	+3,865	New	+$95.4K	0.01%	673

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Meeder Asset Management's PTLA Position: Q2 2020 in Review

Meeder Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 181 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in PTLA in Q2 2016 and held it in 8 quarters. The position peaked at $91K in Q2 2016. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Meeder Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Meeder Asset Management sold 181 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1K.
Meeder Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2016 and held it in 8 quarters.
Meeder Asset Management's Portola Pharmaceuticals, Inc. position peaked at $91K in Q2 2016.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.